Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SARTORIUS (SSSGY : OTC)

• Company Description    Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. Number of Employees: 14,042

• Price / Volume Information    Yesterday's Closing Price: $43.93 Daily Weekly Monthly 20 Day Moving Average: 5 shares Shares Outstanding: 171.19 (millions) Market Capitalization: $7,520.95 (millions) Beta: 0.86 52 Week High: $50.95 52 Week Low: $39.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -0.05% 12 Week 0.00% -1.91% Year To Date -2.37% -13.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OTTO-BRENNER-STRASSE 20 - GOETTINGEN,2M 37079 DEU ph: 49-55-130-80 fax: 49-55-1308-3289 ben.orzelek@sartorius.com http://www.sartorius.com

• General Corporate Information    Officers Joachim Kreuzburg - Chief Executive Officer and Chairman Florian Funck - Chief Financial Officer Rene Faber - Member of the Executive Board Alexandra Gatzemeyer - Member of the Executive Board Rainer Lehmann - Member of the Executive Board Peer Information SARTORIUS (ABMD) SARTORIUS (DMDS) SARTORIUS (CPWY.) SARTORIUS (EQUR) SARTORIUS (ECIA) SARTORIUS (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 80385Q109 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/15/26 Share - Related Items Shares Outstanding: 171.19 Most Recent Split Date: 1.00 (5.00:1) Beta: 0.86 Market Capitalization: $7,520.95 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.21% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.09 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/15/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.62 Price/Cash Flow: 8.85 Price / Sales: 1.80 EPS Growth vs. Year Ago Period: 8.70% vs. Previous Quarter: 7.14% Sales Growth vs. Year Ago Period: 5.65% vs. Previous Quarter: 0.75% ROE 09/30/26 - - 06/30/26 - 7.57 03/31/26 - 7.53 ROA 09/30/26 - - 06/30/26 - 3.04 03/31/26 - 2.95 Current Ratio 09/30/26 - - 06/30/26 - 1.14 03/31/26 - 0.91 Quick Ratio 09/30/26 - - 06/30/26 - 0.56 03/31/26 - 0.52 Operating Margin 09/30/26 - - 06/30/26 - 8.16 03/31/26 - 8.07 Net Margin 09/30/26 - - 06/30/26 - 5.50 03/31/26 - 4.61 Pre-Tax Margin 09/30/26 - - 06/30/26 - 11.33 03/31/26 - 9.85 Book Value 09/30/26 - - 06/30/26 - 27.15 03/31/26 - 26.60 Inventory Turnover 09/30/26 - - 06/30/26 - 2.39 03/31/26 - 2.40 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.91 03/31/26 - 0.86 Debt-to-Capital 09/30/26 - - 06/30/26 - 47.72 03/31/26 - 46.17

Powered by Zacks Investment Research ©